echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 280 pharmaceutical companies released semi-annual reports, most of which showed an upward trend

    280 pharmaceutical companies released semi-annual reports, most of which showed an upward trend

    • Last Update: 2022-09-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 29, seven listed pharmaceutical companies on the Shenzhen Stock Exchange collectively released the 2022 semi-annual announcement, namely Tailin Biological, Xingqi Eye Medicine, Dongbao Pharmaceutical, Northeast Biologics, Northeast Pharmaceutical, Kefu Medical, Aokangsai, and Aoyuan Meigu


    Overall, most of them showed a growth trend, and its Middle East Treasure Bio performed the most eye-catching, with a net profit of 667.


    Tailin Bio: Net profit increased by 13.


    Tailin Bio: Net profit increased by 13.


    Xingqi Eye Medicine: Net profit increased by 50.


    Xingqi Eye Medicine: Net profit increased by 50.


    Northeast Pharmaceutical: Net profit increased by 86.


    Northeast Pharmaceutical: Net profit increased by 86.


    Toho Biotech: Net profit increased by 667.


    Toho Biotech: Net profit increased by 667.


    Kefu Medical: Net profit decreased by 39.


    Kefu Medical: Net profit decreased by 39.


    Aosaicon: Net profit decreased by 95.


    Aosaicon: Net profit decreased by 95.


    Aoyuan Meigu: Net profit decreased by 256.


    Aoyuan Meigu: Net profit decreased by 256.


    280 pharmaceutical companies released semi-annual reports, most of which showed an upward trend
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.